CBD, or cannabidiol, has exploded onto the market in recent years. Between the past decade, this purportedly medicinal marijuana extract go from being an obscure stoner oil to the wellness product or service du jour, flooding from holistic markets to the general. Analysts at the investment bank Cowen Inc. predict the industry will balloon to $16 billion by 2025. In comparison, CENTRAL BUSINESS DISTRICT sales totaled less than $1 billion last year, though that’s virtually no small feat for a field that didn’t exist a long time ago.
CBD oil for anxiety is purported to help with everything from melancholy to chronic pain and some animal studies suggest perhaps it will even help fight cancer, according to the National Cancer Institute. The best compelling evidence for its efficacy at the moment comes from studies with epilepsy patients who have seen their seizures reduced with the help of CBD.
Based in part on its reputed curative properties, the exact compound has recently begun to enter the wider world of individual goods. Inventive cannabis companies have started putting CENTRAL BUSINESS DISTRICT in almost everything: shampoo, protein powders, transdermal patches plus gels, gum, sex lubes, lip balms, vaporizers, antiperspirant, cleanser, cosmetic,, rectal suppositories, sports drinks — you name it. Mike Tyson, Martha Stewart and other public figures have started their lines of CBD products while celebrity doctors Sanjay Gupta and Mehmet Oz have both given endorsements.
“We’ve seen just this incredible growth that I imagine took even the people in this market by surprise, ” suggests Jamie Schau, head of research at Brightfield Collection, one of America’s top marijuana marketing research firms. “We see it ultimately becoming a mainstream nutritional supplement rather than a cannabis merchandise specifically, which has a rather limited audience. ”
But it may be not clear how well some of these products work and the scientific discipline on cannabidiol’s efficacy is still catching up. How otc sales of CBD will be regulated in the future, too, will be uncertain, though an upcoming FDA ruling could change of which. It’s likely CBD sales will continue in some kind, meaning that you’ll probably continue seeing it in day to day products. Whether it will actually do anything for you though, good, that depends.
CBD and You
Contrary to popular belief, cannabidiol actually is psychoactive, meaning it affects the mind. Its psychoactive properties are likely key to its purported effects as a ointment, unguent for anxiety, inflammation, chronic pain and more. What it won’t do, though, is get you stoned. CBD is nonaddictive and has few side effects, according to the World Health Organization, who has recommended lifting restrictions on the drug.
Because CBD is usually nonintoxicating and probably helpful for a range of common conditions, is considered led to an explosion of interest among brands. Want a bit of CBD with your morning coffee? No problem. Maybe in a tub bomb to help you unwind after a stressful day? An craving CBD company has your back. Few of these brands might point to specific published research on their particular product’s efficacy at the moment, though, leaving their marketing departments to exchange in vague promises.